ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,318.00
      0.95%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      81.965
      0.00%
      Bitcoin
      68,937.62
      -0.48%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX
      6. ProMIS Neurosciences Inc (PMN)

      7. ProMIS Neurosciences Inc (PMN) News

      PMN

      ProMIS Neurosciences (PMN)

      ProMIS Neurosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:TSX:PMN
      DateTimeSourceHeadlineSymbolCompany
      04/18/20229:05AMPR Newswire (US)Argus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc. (TSX:PMN & OTCQB: ARFXF)TSX:PMNProMIS Neurosciences Inc
      08/18/20218:15AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - PMNTSX:PMNProMIS Neurosciences Inc
      08/18/20218:13AMPR Newswire (Canada)IIROC Trade Resumption - PMNTSX:PMNProMIS Neurosciences Inc
      08/17/20214:53PMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - PMNTSX:PMNProMIS Neurosciences Inc
      08/17/20214:50PMPR Newswire (Canada)IIROC Trading Halt - PMNTSX:PMNProMIS Neurosciences Inc
      03/22/202110:59AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - PMNTSX:PMNProMIS Neurosciences Inc
      03/22/202110:57AMPR Newswire (Canada)IIROC Trade Resumption - PMNTSX:PMNProMIS Neurosciences Inc
      03/22/202110:47AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - PMNTSX:PMNProMIS Neurosciences Inc
      03/22/202110:45AMPR Newswire (Canada)IIROC Trading Halt - PMNTSX:PMNProMIS Neurosciences Inc
      11/18/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Completes First Closing of Private PlacementTSX:PMNProMIS Neurosciences Inc
      11/14/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Announces Third Quarter 2019 ResultsTSX:PMNProMIS Neurosciences Inc
      11/14/20197:30AMPR Newswire (US)ProMIS Neurosciences Announces Third Quarter 2019 ResultsTSX:PMNProMIS Neurosciences Inc
      11/13/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Undertaking $6.5M Private PlacementTSX:PMNProMIS Neurosciences Inc
      11/07/20197:30AMPR Newswire (US)ProMIS Neurosciences outlines best-in-class approach to amyloid-beta-targeting drug candidates for Alzheimer's diseaseTSX:PMNProMIS Neurosciences Inc
      11/07/20197:30AMPR Newswire (Canada)ProMIS Neurosciences outlines best-in-class approach to amyloid-beta-targeting drug candidates for Alzheimer's diseaseTSX:PMNProMIS Neurosciences Inc
      10/24/20193:00AMPR Newswire (US)ProMIS Neurosciences issues Chairman's update memorandum and white paper on Alzheimer's diseaseTSX:PMNProMIS Neurosciences Inc
      10/24/20193:00AMPR Newswire (Canada)ProMIS Neurosciences issues Chairman's update memorandum and white paper on Alzheimer's diseaseTSX:PMNProMIS Neurosciences Inc
      10/23/20199:49AMPR Newswire (US)ProMIS Neurosciences advances ALS program selectively targeting toxic form of TDP-43TSX:PMNProMIS Neurosciences Inc
      10/23/20197:30AMPR Newswire (Canada)ProMIS Neurosciences advances ALS program selectively targeting toxic form of TDP-43TSX:PMNProMIS Neurosciences Inc
      10/17/20197:30AMPR Newswire (US)ProMIS Neurosciences advances Alzheimer's disease program targeting neurotoxic forms of tauTSX:PMNProMIS Neurosciences Inc
      10/17/20197:30AMPR Newswire (Canada)ProMIS Neurosciences advances Alzheimer's disease program targeting neurotoxic forms of tauTSX:PMNProMIS Neurosciences Inc
      10/08/20197:30AMPR Newswire (US)ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System AtrophyTSX:PMNProMIS Neurosciences Inc
      10/08/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System AtrophyTSX:PMNProMIS Neurosciences Inc
      09/03/20197:30AMPR Newswire (US)ProMIS Neurosciences to Present at HC Wainwright Investment ConferenceTSX:PMNProMIS Neurosciences Inc
      09/03/20197:30AMPR Newswire (Canada)ProMIS Neurosciences to Present at HC Wainwright Investment ConferenceTSX:PMNProMIS Neurosciences Inc
      08/27/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom...TSX:PMNProMIS Neurosciences Inc
      08/27/20197:30AMPR Newswire (US)ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom...TSX:PMNProMIS Neurosciences Inc
      08/13/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Announces Second Quarter 2019 ResultsTSX:PMNProMIS Neurosciences Inc
      08/13/20197:30AMPR Newswire (US)ProMIS Neurosciences Announces Second Quarter 2019 ResultsTSX:PMNProMIS Neurosciences Inc
      07/24/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Announces Results of Annual Meeting of ShareholdersTSX:PMNProMIS Neurosciences Inc
       Showing the most relevant articles for your search:TSX:PMN